Search research articles
Contact Us
Filters
Showing results (121-130 of 141) with videos related to
Page
of 15
Sort By:
Journal of Neurology
|
September 29, 2025
Subjective psychiatric symptoms in post-acute autoimmune encephalitis: findings from the Australian autoimmune encephalitis consortium
Katherine Y Ko, Christina Kazzi, Nabil Seery, et al.
The Lancet. Neurology
|
March 22, 2020
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Anna He, Bernd Merkel, James William L Brown, et al.
Brain Communications
|
June 19, 2026
Acute and longitudinal magnetic resonance imaging abnormalities in antibody-mediated encephalitis
Nabil Seery, Paul Beech, Robb Wesselingh, et al.
JAMA Neurology
|
June 12, 2023
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
Izanne Roos, Stella Hughes, Gavin McDonnell, et al.
Journal of Neurology
|
April 25, 2025
Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium study
Nabil Seery, Robb Wesselingh, Paul Beech, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
June 19, 2025
Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort Study
Nabil Seery, Robb Wesselingh, Paul Beech, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 4, 2022
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS
Tomas Kalincik, Ilya Kister, Tamar E Bacon, et al.
Brain : a Journal of Neurology
|
May 10, 2020
Early clinical markers of aggressive multiple sclerosis
Charles B Malpas, Ali Manouchehrinia, Sifat Sharmin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 30, 2025
Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study
Nabil Seery, Robb Wesselingh, Paul Beech, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 1, 2022
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings
Dhamidhu Eratne, Samantha M Loi, Qiao-Xin Li, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 141) with videos related to
Sort By:
Page
of 15
Journal of Neurology
|
September 29, 2025
Subjective psychiatric symptoms in post-acute autoimmune encephalitis: findings from the Australian autoimmune encephalitis consortium
Katherine Y Ko, Christina Kazzi, Nabil Seery, et al.
The Lancet. Neurology
|
March 22, 2020
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Anna He, Bernd Merkel, James William L Brown, et al.
Brain Communications
|
June 19, 2026
Acute and longitudinal magnetic resonance imaging abnormalities in antibody-mediated encephalitis
Nabil Seery, Paul Beech, Robb Wesselingh, et al.
JAMA Neurology
|
June 12, 2023
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
Izanne Roos, Stella Hughes, Gavin McDonnell, et al.
Journal of Neurology
|
April 25, 2025
Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium study
Nabil Seery, Robb Wesselingh, Paul Beech, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
June 19, 2025
Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort Study
Nabil Seery, Robb Wesselingh, Paul Beech, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 4, 2022
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS
Tomas Kalincik, Ilya Kister, Tamar E Bacon, et al.
Brain : a Journal of Neurology
|
May 10, 2020
Early clinical markers of aggressive multiple sclerosis
Charles B Malpas, Ali Manouchehrinia, Sifat Sharmin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 30, 2025
Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study
Nabil Seery, Robb Wesselingh, Paul Beech, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 1, 2022
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings
Dhamidhu Eratne, Samantha M Loi, Qiao-Xin Li, et al.
Page
of 15